A5028787260- Cardiac pacing and defibrillation studies
- Cardiovascular Function and Risk Factors
- Cardiac Arrhythmias and Treatments
- Cardiac Structural Anomalies and Repair
- Heart Failure Treatment and Management
- Cardiac electrophysiology and arrhythmias
- Cardiomyopathy and Myosin Studies
- Cardiac Imaging and Diagnostics
- Diabetes Treatment and Management
- Atrial Fibrillation Management and Outcomes
- Coronary Interventions and Diagnostics
- Cardiovascular and exercise physiology
- Cardiovascular Effects of Exercise
- Acute Myocardial Infarction Research
- Venous Thromboembolism Diagnosis and Management
- Antiplatelet Therapy and Cardiovascular Diseases
- Potassium and Related Disorders
- Orthopaedic implants and arthroplasty
- Chronic Disease Management Strategies
- Orthopedic Infections and Treatments
- Sports injuries and prevention
- Diabetes Management and Research
- Health Systems, Economic Evaluations, Quality of Life
- Heart Rate Variability and Autonomic Control
- Heart rate and cardiovascular health
University Hospital of Wales
2015-2024
Cardiff and Vale University Health Board
2011-2024
Cardiff University
2011-2022
Cardiff Metropolitan University
2014-2022
International Islamic University Malaysia
2020
University of East Anglia
2017
The Heart Research Institute
2014
Aneurin Bevan University Health Board
2013
Good Hope Hospital
2005-2009
University of Birmingham
2007
Reports on the incidence and causes of sudden cardiac death among young athletes have relied largely estimated rates participation varied methods reporting. We sought to investigate adolescent soccer players in United Kingdom.
AimChronic right ventricle (RV) apical (RVA) pacing is standard treatment for an atrioventricular (AV) block but may be deleterious to left (LV) systolic function. Previous clinical studies of non-apical have produced conflicting results. The aim this randomized, prospective, international, multicentre trial was compare change in LV ejection fraction (LVEF) between ventricular and high septal (RVHS) over a 2-year study period.
To determine whether myocardial scarring, quantified using late gadolinium enhancement-cardiovascular magnetic resonance (LGE-CMR), predicts response to cardiac resynchronization therapy (CRT). A total of 45 patients with ischaemic cardiomyopathy [age 67.1 ± 10.4 years (mean SD)] underwent assessment 6 min walking distance (6MWD) and quality life (QoL) before after CRT. Scar size (percentage left ventricular mass), location, transmurality were assessed prior CRT LGE-CMR. Responders (survived...
Cardiac resynchronization therapy (CRT) is one of the most effective therapies for heart failure with reduced ejection fraction and leads to improved quality life, reductions in hospitalization rates all-cause mortality. Nevertheless, up two-thirds eligible patients are not referred CRT. Furthermore, post-implantation follow-up often fragmented suboptimal, hampering potential maximal treatment effect. This joint position statement from three European Society Cardiology Associations, Heart...
Left ventricular hypertrophy (LVH) is prevalent and associated with a poor long-term prognosis. The Framingham Heart Study, for example, showed that LVH was present in 15–20% of adults, that, each 50 g/m2 increment left mass, the relative risk cardiovascular death increased by 1.73 men 2.12 women.1 Although hypertension, obesity valvulopathies account most causes LVH, it important to investigate patients otherwise unexplained since many are treatable. Although several electrocardiographic...
To provide comprehensive information on the access and use of cardiac implantable electronic devices (CIED) catheter ablation procedures in Africa.The Pan-African Society Cardiology (PASCAR) collected data invasive management arrhythmias from 2011 to 2016 31 African countries. A specific template was completed by physicians, additional obtained industry. Information health care systems, demographics, economics, procedure rates, training programs collected. Considerable heterogeneity...
Cardiac resynchronization therapy (CRT) is one of the most effective therapies for heart failure with reduced ejection fraction and leads to improved quality life, reductions in hospitalization rates all-cause mortality. Nevertheless, up two-thirds eligible patients are not referred CRT. Furthermore, post-implantation follow-up often fragmented suboptimal, hampering potential maximal treatment effect. This joint position statement from three European Society Cardiology Associations, Heart...
It is apparent that despite lack of family history, patients with the morphological characteristics left ventricular non-compaction develop arrhythmias, thrombo-embolism and dysfunction.Forty two patients, aged 48.7 +/- 2.3 yrs (mean SEM) underwent cardiovascular magnetic resonance (CMR) for quantification volumes extent non-compacted (NC) myocardium. The latter was quantified using planimetry on two-chamber long axis LV view (NC area). included those referred specifically CMR to investigate...
To examine the evidence base for telemonitoring designed patients who have chronic obstructive pulmonary disease and heart failure, to assess whether fulfils principles of monitoring is ready implementation into routine settings.Qualitative data collection using interviews participation in a multi-path mapping process.Twenty-six purposively selected informants completed semi-structured 24 individuals with expertise relevant clinical informatics domains from academia, industry, policy...
BRAVO (British Randomized Controlled Trial of AV and VV Optimization) is a multicenter, randomized, crossover, noninferiority trial comparing echocardiographic optimization atrioventricular (AV) interventricular delay with noninvasive blood pressure method.Cardiac resynchronization therapy including confers clinical benefit, but the requires time expertise to perform.This study randomized patients or hemodynamic using multiple-replicate beat-by-beat at baseline; after 6 months, participants...